EXPORT CITATION

Chapter-129 Febuxostat Therapy for Patients with Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

BOOK TITLE: Year Book of Medicine 2019

Author
1. Jha Vivekanand
2. Bharati Joyita
3. Modi Gopesh K
ISBN
9789389188738
DOI
10.5005/jp/books/18366_131
Edition
1/e
Publishing Year
2019
Pages
2
Author Affiliations
1. Postgraduate Institute of Medical, Education and Research, Chandigarh, Coordinator of Stem Cell Research Facility, P.G.I.M.E.R., Chandigarh, India, Postgraduate Institute of Medical Education and Research, Chandigarh, India, The George Institute for Global Health, India; James Martin Fellow, University of Oxford; University of New South Wales, Sydney, Australia; International Society of Nephrology, George Institute for Global Health, India, New Delhi, India; Global Kidney Health Imperial College, London, United Kingdom, The George Institute for Global Health; Fortis Escorts Hospital, New Delhi, India, The George Institute for Global Health, Fortis Escorts Hospital, New Delhi, India, George Institute for Global Health, New Delhi, India; Global Kidney Health, Imperial College, London, UK; Aykai Hospital, Ludhiana, Punjab, India, George Institute for Global Health, New Delhi, India; Chair of Global Kidney Health, Imperial College, London, UK; Aykai Hospital, Ludhiana, Punjab, India
2. Postgraduate Institute of Medical Education and Research Chandigarh, India, Postgraduate Institute of Medical Education and Research, Chandigarh, India
3. Noble Samarpan Kidney Centre, Bhopal, Madhya Pradesh, India, Noble-Samarpan Kidney Centre, Bhopal, Madhya Pradesh, India
Chapter keywords
Febuxostat therapy, asymptomatic hyperuricemia, randomized trial, chronic kidney disease, CKD, epidemiologic study, clinical study, estimated glomerular filtration rate

Abstract

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved